Stevanato Group SpA

STVN: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
HNWLOCK|N#dpLOCK|#>NPxd

Stevanato: Initiating Coverage With a Narrow Moat and USD 21.10 FVE; Shares Fairly Valued

We are initiating coverage on Stevanato, a manufacturer of glass drug packaging and injection devices, including vials, prefilled syringes and cartridges, as well as injection pens and autoinjectors. The company benefits from the overall rise in biologics, as well as peptides and GLP-1 drugs.

Sponsor Center